Bora Pharmaceutical is one of the premier pharmaceutical companies in Taiwan. We are one of the few companies that covers the entire pharmaceutical supply chain from research and development all the way to sales and distribution. We provide outsourced R&D and toll manufacturing services for Taiwan domestic and global pharmaceutical companies around the world. With Bora's USFDA, MHRA, and PIC/S certified facilities, we produce pharmaceuticals at the highest world standards for sales to over 17 countries worldwide. Our mission is to always push the boundaries of product innovation, while maintaining the highest quality standards, and become the key pharmaceutical companies and be your best partner based in Asia to help connect your products to the world. Bora Pharmaceutical has 2 cGMP manufacturing facilities located in Zhunan and Tainan. Both plants are built with the highest international standards of manufacturing, packaging, pharmaceutical R&D, and analytical testing. Zhunan plant is USFDA, EU MHRA and TFDA-approved for sales to Taiwan, US, EU countries. Tainan site is PIC/S GMP-certified by TFDA, Jordan FDA, and GCC(Gulf Cooperation Council) GMP certified for sales to 16 countries covering Southeast Asia, and Southwest Asia, Middle East, and Central America.
外部Bora Pharmaceuticals連結
Bora Pharmaceuticals轉發了此項目
Service Provider for Mississauga, Brampton, and Caledon across Region of Peel
What a way to kick-start spring with a special bike donation from our partners at Bora Pharmaceuticals for the kids across our BGC Peel Club. #OpportunityChangesEverything www.bgcpeel.org
Last week, Bora Pharmaceuticals participated in the Biotech Job Fair & Networking Event at Montgomery College. We appreciated the opportunity to share our mission, connect with talented professionals, and support those impacted by recent changes in government research roles. Thank you to the organizers for creating such a meaningful and well-rounded event, and thank you to Vera Biles and Nick Droste for representing Bora. #Biotech #STEMCareers #MontgomeryCollege
Join us TODAY for Fierce Biotech's Virtual Event: "Advancing Complex Biologics into Real Treatments: Technologies, Experts and Partners to Know in 2025." Tune in at 12:15 pm EDT to hear from Bora Biologics CEO Steve Lam and Bora Pharmaceuticals CDMO Division President J.D. Mowery as they discuss a new model for reliable global biologics supply and share their insights on the challenges, opportunities, and advancements in biologics development and manufacturing. Register now ➡️ https://bit.ly/4iekv7l #Biologics #BiotechPartnerships #CDMO
We were honored to have recently hosted a delegation from the Stanford University Graduate School of Business, led by Yu Ding, as part of their Global Study Trip focused on healthcare in Asia — with Singapore and Taiwan as key destinations. During the visit, our CEO Bobby Sheng shared insights on the key drivers behind Bora Pharmaceuticals’ rapid growth — from our world-class manufacturing capabilities to our unique "Glocal" service mindset that sets us apart as a leading and transformative CDMO. The group also toured our Zhunan manufacturing site, where they got a firsthand look at our advanced operations in specialized oral solid dosage (OSD) delivery systems. Thank you Stanford GSB for the engaging exchange!
Join us next Wednesday, April 9th for Fierce Biotech's Virtual Event: "Advancing Complex Biologics into Real Treatments: Technologies, Experts and Partners to Know in 2025." Hear from Bora Biologics CEO Steve Lam and Bora Pharmaceuticals CDMO Division President J.D. Mowery as they discuss a new model for reliable global biologics supply and share their insights on the challenges, opportunities, and advancements in biologics development and manufacturing. Register for the event today: https://bit.ly/42DloAH 📅 Wednesday, April 9, 2025 🕦 11:50am – 12:10pm EDT #Biologics #BiotechPartnerships #CDMO
Heading to CPHI Japan in Tokyo next week? SoonKyu(Austin) Shin, Director, Business Development will be in attendance and is looking forward to connecting with the global pharma community to discuss how Bora's comprehensive CDMO solutions and expansive network can help bring your products to market. Schedule a meeting ➡️https://bit.ly/4iQlz2r
It's time to start planning for the largest and most comprehensive biotechnology event of the year, ✨ BIO International Convention✨ The Bora Group is excited to be heading to Boston, June 16 - 19, to connect with biopharma innovators and discuss the latest cutting-edge breakthroughs, advancements, and trends in biologics development and manufacturing. ✅ Learn how Bora Biologics' specialized expertise, enhanced capabilities, and latest strategic investments can help accelerate your product to commercial success. ✅Explore our end-to-end solutions, including Bora's sterile fill/finish capabilities at our cGMP facility in Baltimore, MD, USA. ✅ Discover a partnership dedicated to quality, innovation, and customer satisfaction. Arrange a meeting with us ➡️ https://bit.ly/4c7D8s1 #BIO2025 #CDMO
Facility Spotlight: 📍Maple Grove, MN, USA This state-of-the-art facility is designed to deliver exceptional quality and reliability at every step of the drug development process for a broad range of dosage forms, including oral solids, powders, and liquids ⤵️ 🏭 Key Facility Highlights: 🔸 270,000 sq feet of manufacturing space 🔸 Robust quality control labs and a dedicated R&D team to support product and analytical development 🔸 Extensive experience in complex OSD development and manufacturing 🔸 US FDA and DEA approved to develop and commercialize a broad range of dosage forms including: oral solids, powders, and liquids Discover how Bora's team, technologies, and expertise can help advance your product to market: https://bit.ly/4hNtPih #OSD #CDMO #SmallMolecules
That's a wrap on another successful #DCATWeek. The Bora team had an engaging and productive four days connecting with new customers, strengthening existing partnerships, and networking with industry peers. We also had the opportunity to present at the Member Company Announcement Forum where we unveiled our plans to integrate AI across the infrastructure of Bora to revolutionize efficiency and patient-centric operations. A special thank you to all those who joined us for our customer reception on Tuesday evening at Nubeluz in NYC. It was the perfect atmosphere and opportunity to express our appreciation to our valued customers, partners, and colleagues for their continued collaboration and support. If we missed you this week, schedule another time to meet with us and be sure to catch us at #BIOInternational in June ➡️https://bit.ly/4hvHH0t
What a terrific evening last night celebrating the 2025 CDMO Leadership Awards with our valued clients, partners, and fellow industry peers. In addition to being a winner in the Biologics and Small Molecule Dosage Form Global Categories, Bora also took home the award for Best "New or Transformed CDMO" 🏆 Thank you to Outsourced Pharma and Life Science Connect for this recognition! Powered by Bora's unique culture and the strength of our people, we are proud to support our clients in the development and manufacturing of life-saving, life-enhancing therapies for patients worldwide. Read the full announcement here ➡️https://bit.ly/4hrPtIK